LYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) INJECTION Trademark

Trademark Overview

On Wednesday, September 4, 2013, a trademark application was filed for LYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) INJECTION with the United States Patent and Trademark Office. The USPTO has given the LYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) INJECTION trademark a serial number of 86055675. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, November 29, 2021. This trademark is owned by Navidea Biopharmaceuticals, Inc.. The LYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) INJECTION trademark is filed in the Pharmaceutical Products category with the following description:

Radiolabelled lymphatic tissue reagents for clinical use containing in substantial part tilmanocept
lymphoseek (technetium tc 99m tilmanocept) injection

General Information

Serial Number86055675
Word MarkLYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) INJECTION
Filing DateWednesday, September 4, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, November 29, 2021
Registration Number4800275
Registration DateTuesday, August 25, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 2, 2014

Trademark Statements

Description of MarkThe mark consists of the wording "LYMPHOSEEK" followed by a diamond design with arrows at each corner of the design all appearing above the wording "(TECHNETIUM TC 99M TILMANOCEPT) INJECTION".
Goods and ServicesRadiolabelled lymphatic tissue reagents for clinical use containing in substantial part tilmanocept
Pseudo MarkLYMPHO SEEK (TECHNETIUM TC 99M TILMANOCEPT) INJECTION
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"(TECHNETIUM TC 99M TILMANOCEPT) INJECTION"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 12, 2013
Primary Code005
First Use Anywhere DateWednesday, March 13, 2013
First Use In Commerce DateWednesday, March 13, 2013

Trademark Owner History

Party NameCARDINAL HEALTH 414, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressDUBLIN, OH 43017
Party NameNavidea Biopharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDublin, OH 43017
Party NameNavidea Biopharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin, OH 43017
Party NameNavidea Biopharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin, OH 43017

Trademark Events

Event DateEvent Description
Saturday, September 7, 2013NEW APPLICATION ENTERED
Tuesday, May 27, 2014EXAMINERS AMENDMENT -WRITTEN
Thursday, September 12, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 13, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, December 16, 2013ASSIGNED TO EXAMINER
Monday, December 30, 2013NON-FINAL ACTION WRITTEN
Monday, December 30, 2013NON-FINAL ACTION E-MAILED
Monday, December 30, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 23, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 23, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 23, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 27, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, May 27, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 27, 2014EXAMINER'S AMENDMENT ENTERED
Friday, August 22, 2014NON-FINAL ACTION E-MAILED
Tuesday, May 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 10, 2014ASSIGNED TO LIE
Friday, June 13, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, June 29, 2014WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, July 17, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, August 22, 2014NON-FINAL ACTION WRITTEN
Friday, August 22, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 27, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 6, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 10, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 10, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 20, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 25, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 2, 2014PUBLISHED FOR OPPOSITION
Tuesday, December 2, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, July 24, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 25, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, October 12, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 5, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 5, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 9, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, June 9, 2015USE AMENDMENT FILED
Wednesday, July 8, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 7, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 23, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 25, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 19, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 12, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 3, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, October 4, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 4, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 29, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, November 29, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, November 22, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, August 25, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

injection tilmanocept technetium lymphoseek substantial part containing clinical lymphatic tissue reagents radiolabelled